Peter Cicala

Director at Ernexa Therapeutics.

Raised on Ernexa Therapeutics filings

$7.2M

of $7.2M offered across 1 Form D filing

Form D filings: 1
Teammates: 5
Last filing: Apr 11, 2025

Company

Ernexa Therapeutics

Biotech · Cambridge, MA

Off-the-shelf stem cell therapy for ovarian cancer

Off-the-shelf stem cell therapy for ovarian cancer

Investors: 15

Investors: 15
Sector: Biotech
HQ: Cambridge, MA

Ernexa Therapeutics filings

Ernexa Therapeutics Form D filings
Filed	Security	Sold of offered	Filing
Apr 11, 2025	Equity	$7.2M/ $7.2M	Form D

EquityFiled Apr 11, 2025Form D
$7.2M/ $7.2M

Works with

Also named on Ernexa Therapeutics filings

Sandra GurrolaSr. Vice President of Finance, Form D signerForm D signer William WexlerDirector Elena RatnerDirector James BristolDirector Sanjeev LutherExecutive Officer, Director